姚尚鹏, 邹婉吉, 王帅. 多参数MRI成像技术用于前列腺癌病理和分期的预测价值研究[J]. 中国辐射卫生, 2021, 30(5): 628-631.
YAO Shangpeng, ZOU Wanji, WANG Shuai. Predictive value of multiparametric MRI for prostate cancer pathology and tumor staging. , 2021, 30(5): 628-631.
[1] Attard G, Parker C, Eeles RA, et al. Prostate cancer[J]. Lancet, 2016, 387(10013): 70-82. DOI: 10.1016/S0140-6736(14)61947-4 [2] Zhai Z, Zheng Y, Li N, et al. Incidence and disease burden of prostate cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017[J]. Cancer, 2020, 126(9): 1969-1978. DOI: 10.1002/cncr.32733 [3] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660 [4] Launer BM, Lloyd GL. Sociodemographic index and global trends in prostate cancer: 1990-2017[J]. Prostate, 2021, 81(12): 825-831. DOI: 10.1002/pros.24178 [5] Liu X, Yu C, Bi Y, et al. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China[J]. Public Health, 2019, 172: 70-80. DOI: 10.1016/j.puhe.2019.04.016 [6] Reese AC. Prostate Cancer (Second Edition): Science and Clinical Practice[J]. Pittsburgh: Academic Press, 2016: 353-360. DOI: 10.1016/B978-0-12-800077-9.00039-6. [7] Cheng L, Montironi R, Bostwick DG, et al. Staging of prostate cancer[J]. Histopathology, 2012, 60(1): 87-117. DOI: 10.1111/j.1365-2559.2011.04025.x [8] Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging - reporting and data system: 2015, version 2[J]. Eur Urol, 2016, 69(1): 16-40. DOI: 10.1016/j.eururo.2015.08.052 [9] Egevad L, Delahunt B, Evans AJ, et al. International society of urological pathology (ISUP) grading of prostate cancer[J]. Am J Surg Pathol, 2016, 40(6): 858-861. DOI: 10.1097/pas.0000000000000642 [10] Matoso A, Epstein JI. Defining clinically significant prostate cancer on the basis of pathological findings[J]. Histopathology, 2019, 74(1): 135-145. DOI: 10.1111/his.13712 [11] 邵志红, 王伟, 刘卫英, 等. 多参数MRI评估前列腺癌主要病灶体积的价值[J]. 同济大学学报,2021,42(2):214-219, 225. DOI: 10.12289/j.issn.1008-0392.20362 Shao ZH, Wang W, Liu WY, et al. Value of multiparametric MRI sequences in evaluating the index lesion volume of prostate cancer[J]. J Tongji Univ Med Sci, 2021, 42(2): 214-219, 225. DOI: 10.12289/j.issn.1008-0392.20362 [12] 邵志红, 王伟, 刘卫英, 等. 双参数与多参数MRI对不同PSA水平前列腺癌诊断的对比研究[J]. 同济大学学报,2020,41(4):437-442. DOI: 10.16118/j.1008-0392.2020.04.006 Shao ZH, Wang W, Liu WY, et al. Biparametric and multiparametric MRI for diagnosis of prostate cancer in patients with different PSA levels[J]. J Tongji Univ Med Sci, 2020, 41(4): 437-442. DOI: 10.16118/j.1008-0392.2020.04.006 [13] 姬广海, 郑义, 孛茹婷, 等. 多参数MRI对中央腺体前列腺癌的诊断价值[J]. 中国医学影像学杂志,2016,24(8):591-595. DOI: 10.3969/j.issn.1005-5185.2016.08.010 Ji GH, Zheng Y, Bo RT, et al. Multiparametric MRI in the diagnosis of prostatic central gland cancer[J]. Chin J Med Imaging, 2016, 24(8): 591-595. DOI: 10.3969/j.issn.1005-5185.2016.08.010 [14] Xu LL, Zhang G, Shi B, et al. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer[J]. Cancer Imaging, 2019, 19(1): 90. DOI: 10.1186/s40644-019-0274-9 [15] Kam J, Yuminaga Y, Krelle M, et al. Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study[J]. BJU Int, 2019, 124(2): 297-301. DOI: 10.1111/bju.14696 [16] Goldman H, Singh N, Harding C, et al. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location[J]. ANZ J Surg, 2019, 89(1/2): 106-110. DOI: 10.1111/ans.14754
